1Walker RI.Considerations for development of whole cell bacterial vaccines to prevent diarrheal diseases in children in developing countries.Vaccine.2005(26):3369-3385.
2Paiardini M,Frank I,Pandrea I et al.Mucosal immune dysfunction in AIDS pathogenesis.Aids Rev.2008,(01):36-46.
3Ashkenazi S,Vertruyen A,Arístegui J,et al.Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.The Pediatric infectious disease journal.2006(10):870.
4Chen Z,Aspelund A,Kemble G,et al.Genetic mapping of the cold-adapted phenotype of B/Ann Arbor/1/66,the master donor virus for live attenuated influenza vaccines(Flu Mist?).Virology.2006(02):416-423.
5Fleming DM,Crovari P,Wahn U,et al.Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine,trivalent,with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.The Pediatric infectious disease journal.2006(10):860.
6Belshe R,Lee MS,Walker RE et al.Safety,immunogenicity and efficacy of intranasal,live attenuated influenza vaccine.Expert review of vaccines.2004(06):643-654.
7Han YW,Kim SB,Rahman M et al.Systemic and mucosal immunity induced by attenuated Salmonella enterica serovar Typhimurium expressing ORF7 of porcine reproductive and respiratory syndrome virus.Comparative immunology,microbiology and infectious diseases.2011(04):1-11.
8Organization WH.Cholera vaccines:WHO position paper.Wkly Epidemiol Rec.2010(13):117-128.
9Lucas MES,Deen JL,Von Seidlein L et al.Effectiveness of mass oral cholera vaccination in Beira,Mozambique.New England Journal of Medicine.2005(8):757-767.
10Yang HH,Kilgore PE,Yang LH et al.An outbreak of typhoid fever,Xing-An County,People's Republic of China,1999:estimation of the field effectiveness of Vi polysaccharide typhoid vaccine.Journal of Infectious Diseases.2001(12):1775-1780.
